Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Small Pilot Study to Develop Biomarkers of Weekly Brodalumab Administration in Hidradenitis Suppurativa Patients

NCT04979520 is registered in ClinicalTrials.gov with Rockefeller University as lead sponsor.

NCT NCT04979520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04979520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Small Pilot Study to Develop Biomarkers of Weekly Brodalumab Administration in Hidradenitis Suppurativa Patients
Lead sponsor
Rockefeller University
Phase
Phase 1
Overall status
Completed
Start date
August 5, 2021
Completion date
July 25, 2022
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne inversa, hidradenitis suppurativa